CFO at Bio-Techne (TECH) exercises 62,000 options and settles taxes in shares
Rhea-AI Filing Summary
BIO-TECHNE Corp CFO James Hippel reported compensation-related equity activity. On May 5, 2026, he exercised 62,000 shares of stock options into common stock at an exercise price of $47.60 per share, converting a derivative award into direct share ownership.
On the same date, 56,955 shares of common stock were disposed of in a tax-withholding transaction at $56.68 per share, covering exercise price or tax obligations rather than representing an open-market sale. Following the exercise, his direct common stock holdings were 210,625 shares, and after tax withholding they were 153,670 shares, while he retained a substantial portfolio of unexercised options and restricted stock units.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 5,045 shares
Net Buy
16 txns
Insider
Hippel James
Role
CFO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Options (Right to Buy) | 62,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 62,000 | $47.60 | $2.95M |
| Exercise Price or Tax Liability | Common Stock | 56,955 | $56.68 | $3.23M |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Performance Restricted Stock Units | -- | -- | -- |
| holding | Performance Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Performance Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Performance Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Stock Options (Right to Buy) — 431,124 shares (Direct);
Common Stock — 153,670 shares (Direct);
Performance Restricted Stock Units — 67,347 shares (Direct);
Performance Stock Options (Right to Buy) — 37,314 shares (Direct);
Restricted Stock Units — 41,809 shares (Direct)
Footnotes (12)
- F1. Fully exercisable.
- F2. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
- F3. Options to purchase 11,305 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026.
- F4. Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F5. Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026.
- F6. Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F7. 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027.
- F8. Options to purchase 8,104 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 8,105 shares vest on 8/15/2028.
- F9. 11,545 restricted stock units vest on 11/1/2026; and 11,544 restricted stock units vest on 11/1/2027.
- F10. Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F11. 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028.
- F12. Options to purchase 12,544 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.
Key Figures
Options exercised: 62,000 shares
Option exercise price: $47.60 per share
Shares used for tax/exercise: 56,955 shares
+4 more
7 metrics
Options exercised
62,000 shares
Stock options converted to common stock on May 5, 2026
Option exercise price
$47.60 per share
Exercise price for 62,000 options
Shares used for tax/exercise
56,955 shares
Common stock delivered at $56.68 to cover tax or exercise costs
Tax-withholding price
$56.68 per share
Price for code F disposition of 56,955 common shares
Shares after exercise
210,625 shares
Direct common stock holdings after option exercise
Shares after tax withholding
153,670 shares
Direct common stock holdings after code F disposition
Largest remaining option block
167,328 shares at $66.97
Unexercised stock options expiring August 5, 2027
Key Terms
Restricted Stock Units, Performance Restricted Stock Units, Performance Stock Options (Right to Buy), tax-withholding disposition, +2 more
6 terms
Restricted Stock Units financial
"security_title": "Restricted Stock Units""
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Performance Restricted Stock Units financial
"security_title": "Performance Restricted Stock Units""
Performance restricted stock units (PRSUs) are promises to deliver company shares to employees or executives only if the business meets specific performance targets and any time-based holding rules. Think of them as a bonus that converts into stock only after set goals are reached, so investors watch PRSUs for two reasons: they can dilute existing shares if paid out, and they signal how closely management’s pay is tied to company performance.
Performance Stock Options (Right to Buy) financial
"security_title": "Performance Stock Options (Right to Buy)""
tax-withholding disposition financial
"transaction_action": "tax-withholding disposition""
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
derivative exercise/conversion financial
"transaction_action": "derivative exercise/conversion""
exercise price financial
"conversion_or_exercise_price": "47.6000""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did BIO-TECHNE Corp (TECH) CFO James Hippel report on this Form 4?
James Hippel reported an option exercise and related tax withholding. He exercised 62,000 stock options at $47.60 per share and 56,955 shares of common stock were withheld at $56.68 per share to cover exercise price or tax obligations, changing his direct shareholdings.
How many BIO-TECHNE (TECH) stock options did the CFO exercise and at what price?
The CFO exercised 62,000 stock options at $47.60 per share. These options converted into 62,000 shares of common stock on May 5, 2026, reflecting the use of a previously granted equity award rather than an open-market purchase of new shares.
What are James Hippel’s BIO-TECHNE (TECH) common stock holdings after these transactions?
After the option exercise, Hippel directly held 210,625 common shares. Following the tax-withholding disposition of 56,955 shares, his direct holdings were 153,670 shares, according to the totals reported in the Form 4 for the non-derivative common stock transactions.
What derivative awards and RSUs does the BIO-TECHNE (TECH) CFO still hold?
The CFO retains multiple option and restricted stock unit awards. Remaining positions include stock options on 167,328 shares at a $66.97 exercise price, additional options at higher prices, and various restricted and performance restricted stock units tied to future vesting and performance conditions.